Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 6,081 | 10,380 | 7,162 | 2,340 | 1,790 |
| Cost of Goods | 386 | 206 | 292 | 48 | N/A |
| Gross Profit | 5,695 | 10,174 | 6,870 | 2,292 | 1,790 |
| Operating Expenses | 37,520 | 43,343 | 36,374 | 32,439 | 38,556 |
| Operating Income | -31,439 | -32,963 | -29,212 | -30,099 | -36,766 |
| Interest Expense | 4,208 | 4,147 | 3,690 | 2,634 | 2,656 |
| Other Income | 2,175 | 2,380 | 227 | 107,775 | -11 |
| Pre-tax Income | -33,472 | -34,730 | -32,675 | 75,042 | -39,433 |
| Income Tax | -1,538 | N/A | 1,637 | 1,752 | N/A |
| Net Income Continuous | -31,934 | -34,730 | -34,312 | 73,290 | -39,433 |
| Net Income | $-31,934 | $-34,730 | $-34,312 | $73,290 | $-39,433 |
| EPS Basic Total Ops | -0.61 | -0.67 | -0.86 | 1.93 | -1.06 |
| EPS Basic Continuous Ops | -0.61 | -0.67 | -0.89 | 1.97 | -1.06 |
| EPS Diluted Total Ops | -0.61 | -0.67 | -0.82 | 1.89 | -1.06 |
| EPS Diluted Continuous Ops | -0.61 | -0.67 | -0.85 | 1.93 | -1.06 |
| EPS Diluted Before Non-Recurring Items | -0.61 | -0.67 | -0.76 | -0.35 | N/A |
| EBITDA(a) | $-31,555 | $-32,967 | $-28,652 | $-29,945 | $-36,443 |